MedPath
NMPA Approval

Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ)

国药准字HJ20230077

December 18, 2023

Drug Information

达格列净二甲双胍缓释片(Ⅰ)

片剂

达格列净5mg(以C₂₁H₂₅ClO₆计)和盐酸二甲双胍500mg

化学药品

December 18, 2023

June 20, 2028

Company Information

Applicant Company

ASTRAZENECA AB

SE-151 85 Södertälje, Sweden

Manufacturing Company

4601 Highway 62 East, Mount Vernon, IN 47620 United States of America

© Copyright 2025. All Rights Reserved by MedPath